Page 621 - Small Animal Internal Medicine, 6th Edition
P. 621

CHAPTER 36   Hepatobiliary Diseases in the Dog   593


            generally avoid them because of the lack of evidence and   with confirmed leptospirosis or bartonellosis) because they
            potential side effects.                              are potentially hepatotoxic.
  VetBooks.ir  Antifibrotics                                       Treatment of portal hypertension
                                                                   Dogs with chronic hepatitis presenting with clinical signs
              The most effective antifibrotic treatment in the context of
            chronic hepatitis is to effectively treat the underlying cause.
                                                                 potentially acquired PSS) have specific management consid-
            Fig. 36.4 illustrates the potential for reversal of fibrosis and   of portal hypertension (ascites, gut wall congestion, and
            even early cirrhosis if the underlying cause is treated. This   erations. The treatment of HE associated with acquired PSS
            has been well described in human medicine but poorly doc-  is the same as the treatment of HE associated with congenital
            umented in canine chronic hepatitis. Later in the disease   PSS (see later in this chapter).
            process, when there is extensive fibrosis, the direct antifi-  The treatment of ascites associated with portal hyperten-
            brotic agent colchicine can be used. However, the author   sion in chronic hepatitis revolves around the use of diuretics,
            does not recommend its use as there is no good evidence of   first aldosterone antagonists (spironolactone, 1-2 mg/kg PO
            efficacy and it has a high incidence of side effects. It is dif-  q12h) and then the addition of furosemide (2 mg/kg PO
            ficult to believe that colchicine is an effective antifibrotic in   q12h) if necessary in refractory cases. The reason spirono-
            the liver of dogs given that no effective hepatic antifibrotic   lactone is the diuretic of choice in these dogs is due to the
            has been identified in humans, in spite of years of research   underlying  pathophysiology  with  increase  in  aldosterone
            (Friedman, 2010). Spironolactone may also have some anti-  and fluid retention described in Chapter 33. Spironolactone
            fibrotic activity. This has been demonstrated in rats with   usually takes 2 or 3 days to reach full effect, and the resolu-
            chronic hepatitis, so there is an argument to use it.  tion of ascites can be monitored by weighing the patient
              Antibiotics                                        daily; any acute changes in weight will be caused by fluid
              There is a primary indication for the use of antibiotics in   shifts. Dietary sodium restriction has also been recom-
            dogs  with  ascending  biliary  tract  infections  or  suspected   mended, although it is unclear how effective or important
            bacterial infection as a cause of chronic hepatitis. The latter   this is. However, it is certainly wise to refrain from feeding
            is rarely proven, but if an atypical leptospiral infection might   the patient high-salt snacks and treats.
            be present (e.g., if chronic granulomatous hepatitis is seen in   It is important to monitor serum electrolyte concentra-
            a dog with access to sources of infection, such as rivers or   tions, mainly sodium and potassium, daily during the first
            ditches), a course of appropriate antibiotics would be wise to   few days of treatment and every few weeks to months there-
            rule this out. The recommended therapy for leptospiral   after, depending on how stable the dog and drug doses are.
            infections is to start with intravenous (IV) amoxicillin,   Hypokalemia should be avoided because it can precipitate
            22 mg/kg q12h, to terminate replication and reduce poten-  HE (see later), but it is less likely in a dog on aldosterone
            tially fatal liver and kidney complications. If leptospiral   antagonists and loop diuretics than in a dog on furosemide
            infection is subsequently confirmed by rising titers on serol-  alone. Hyponatremia can also occur; if it is marked, the
            ogy, dark field microscopy, PCR assay of the urine or blood   diuretics  should  be  stopped  and the  patient given careful
            for organisms, or fluorescent in-situ hybridization of live   IV replacement until the sodium level is normalized. Thera-
            biopsies, this should be followed by doxycycline therapy   peutic paracentesis is indicated only for patients with ascites
            (5 mg/kg PO q12h, for 2 weeks) once liver function has   that is severe enough to compromise breathing. This is
            normalized to eliminate the chronic renal carrier state. For   actually unusual and is manifested by severe ascites with
            additional information on leptospirosis, see Chapter 94. Bar-  a tense abdomen and the dog is unable to settle and lie
            tonella spp. have occasionally been associated with chronic   down. Paracentesis should be accompanied by concurrent
            liver disease in dogs, but the optimal treatment for Bartonella   IV administration of a colloid plasma expander, plasma,
            infection in dogs has not been established. Macrolides (e.g.,   or albumin; removal of a large volume of fluid contain-
            erythromycin) or alternatively fluoroquinolones or doxycy-  ing albumin can result in a precipitous hypoalbuminemia
            cline have been shown to have some efficacy against some   and decrease in oncotic pressure, leading to pulmonary
            Bartonella spp. in dogs. It has been suggested that 4 to 6   edema. This is a real problem in dogs with chronic liver
            weeks of treatment might be necessary to eliminate infection   disease in which the liver’s capacity to manufacture albumin
            (see Chapter 94).                                    is reduced.
              Antibiotics are also used as part of supportive treatment   Dogs with portal hypertension are at risk of GI ulceration
            in dogs with HE caused by acquired PSS in end-stage chronic   due to splanchnic congestion, as described earlier and in
            hepatitis; they are given in a similar way as to dogs with   Chapter 33. The clinician must be aware that GI ulceration
            congenital PSS to reduce toxin absorption from the gut and   may occur acutely in dogs with splanchnic congestion, and
            risk of systemic infections (see later). Ampicillin or amoxicil-  serious clinical deterioration may occur before melena is
            lin is often used long term in these cases, 10 to 20 mg/kg PO   apparent because it takes several hours for the blood to pass
            q8-12h.                                              from the small to large intestine. Before this occurs, it is
              As with other drugs, the clinician should avoid any antibi-  possible for the animal to show sudden onset and marked
            otics that increase hepatic work or the risk of hepatotoxicity.   signs of HE because blood is a high-protein meal in the small
            Thus tetracyclines, potentiated sulfonamides, nitrofurantoin,   intestine (see earlier) or even for the ulcer to perforate and
            and erythromycin should be avoided unless necessary (e.g.,   cause peritonitis (Fig. 36.5).
   616   617   618   619   620   621   622   623   624   625   626